161 related articles for article (PubMed ID: 12364862)
1. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant.
Roberts CA; Stern DL; Radio SJ
Transplantation; 2002 Sep; 74(6):817-21. PubMed ID: 12364862
[TBL] [Abstract][Full Text] [Related]
2. Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A?
Hudnall SD
Transplantation; 2002 Sep; 74(6):757-8. PubMed ID: 12369583
[No Abstract] [Full Text] [Related]
3. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.
Chang RK; McDiarmid SV; Alejos JC; Drant SE; Klitzner TS
Pediatr Transplant; 2001 Jun; 5(3):187-91. PubMed ID: 11422821
[TBL] [Abstract][Full Text] [Related]
4. Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients.
O'Gorman MA; Fivush B; Wise B; Colombani P; Burdick J; Schwarz KB
Clin Transplant; 1995 Aug; 9(4):312-6. PubMed ID: 7579739
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ
J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
[TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
7. Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus.
Ericzon BG; Eusufzai S; Söderdahl G; Duraj F; Einarsson K; Angelin B
Transplantation; 1997 Jan; 63(1):74-80. PubMed ID: 9000664
[TBL] [Abstract][Full Text] [Related]
8. Increase in de novo food allergies after pediatric liver transplantation: tacrolimus vs. cyclosporine immunosuppression.
Lebel MJ; Chapdelaine H; Paradis L; Des Roches A; Alvarez F
Pediatr Transplant; 2014 Nov; 18(7):733-9. PubMed ID: 25156571
[TBL] [Abstract][Full Text] [Related]
9. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
[TBL] [Abstract][Full Text] [Related]
10. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
Taler SJ; Textor SC; Canzanello VJ; Wilson DJ; Wiesner RH; Krom RA
Am J Hypertens; 1995 Jun; 8(6):598-605. PubMed ID: 7544983
[TBL] [Abstract][Full Text] [Related]
11. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
[TBL] [Abstract][Full Text] [Related]
12. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
[TBL] [Abstract][Full Text] [Related]
13. The role of testosterone in cyclosporine-induced osteopenia.
Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S
J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
[TBL] [Abstract][Full Text] [Related]
14. FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations.
Hytiroglou P; Lee R; Sharma K; Theise ND; Schwartz M; Miller C; Thung SN
Transplantation; 1993 Dec; 56(6):1389-94. PubMed ID: 7506452
[TBL] [Abstract][Full Text] [Related]
15. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
[TBL] [Abstract][Full Text] [Related]
16. Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?
Therapondos G; Plevris JN; Dollinger MM; Hayes PC; Flapan AD
Transplantation; 2003 Jul; 76(2):446-7; author reply 447-8. PubMed ID: 12883220
[No Abstract] [Full Text] [Related]
17. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.
Textor SC; Wiesner R; Wilson DJ; Porayko M; Romero JC; Burnett JC; Gores G; Hay E; Dickson ER; Krom RA
Transplantation; 1993 Jun; 55(6):1332-9. PubMed ID: 7685934
[TBL] [Abstract][Full Text] [Related]
18. Administration of tacrolimus in 50 liver transplantation patients.
Ye QF; Ruzig MA; Gong NQ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
[TBL] [Abstract][Full Text] [Related]
19. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
Pirenne J; Benedetti E; Gruessner A; Moon C; Hakim N; Fryer JP; Troppmann C; Nakhleh RE; Gruessner RW
Transplantation; 1996 Jun; 61(12):1685-94. PubMed ID: 8685944
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression.
Pham H; Lemoine A; Salvucci M; Azoulay D; Frenoy N; Samuel D; Reynès M; Bismuth H; Debuire B
Liver Transpl Surg; 1998 Mar; 4(2):146-51. PubMed ID: 9516567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
